Herbal Supplements Market
This article was originally published in The Tan Sheet
U.S. retail sales of herbal supplements could approach $6 bil. in 2006, up from $4.1 bil. in 2000 and $2.8 bil. in 1996, a compound annual growth rate of 6%, Datamonitor forecasts in a consumer trends analysis released Aug. 6. The markets for herbal supplements, vitamins and minerals, and OTC drugs all benefit from consumers' growing concerns about health, reflected in an increased interest in self-medication and adoption of health regimens. Datamonitor notes that "functional health" products, such as nutraceuticals, have "substantially outperformed the level of overall market growth and this trend is expected to continue," with annual U.S. retail sales projected to reach about $3.5 bil. in 2007. Additional factors driving consumer spending include convenience, age complexity (children acting older, adults acting younger), individualism, and sensory appeal, according to the 1"Global Consumer Trends" report. Details and purchasing information are available by contacting 800-759-0261 or email@example.com...
You may also be interested in...
Liquid biopsy start-up Grail Inc. announced that a study of almost 6,700 participants found that its blood test could detect more than 50 types of cancer with a low false-positive rate. See what Minetta Liu, study co-lead author and a Mayo Clinic professor of oncology, had to say about the research.
Sanofi’s next-generation meningococcal vaccine, broader use of Bristol-Myers Squibb’s Reblozyl move toward approval; United Therapeutics foreshadows Trevyent regulatory difficulties.
Biopharma is working on a reputation renaissance as the public looks to industry for treatments and vaccines for the COVID-19 epidemic and drug pricing concerns take a back seat.